Induction and adjuvant chemotherapy for head and neck cancer: Future perspectives

Research output: Contribution to journalArticle

Abstract

Induction and adjuvant chemotherapy for head and neck cancer: future perspectives. Induction and adjuvant chemotherapy have been studied in combined modality trials over the last two decades. Induction chemotherapy as a strategy has failed to improve survival or local-regional control although some studies have reported a decrease in the rate of development of distant metastases. The role of induction chemotherapy is limited to preserving the larynx for patients with larynx or hypopharynx primaries. Trials of adjuvant chemotherapy or chemoradiation in resected patients suggest benefit for those with high risk features (multiple involved nodes, extracapsular extension, positive surgical margin). Definitive randomized studies are in progress in the United States and Europe. New targeted therapies will be investigated in future trials to improve survival.

Original languageEnglish (US)
Pages (from-to)277-280
Number of pages4
JournalActa Oto-Rhino-Laryngologica Belgica
Volume53
Issue number3
StatePublished - 1999

Fingerprint

Induction Chemotherapy
Adjuvant Chemotherapy
Head and Neck Neoplasms
Larynx
Hypopharynx
Survival
Neoplasm Metastasis
Therapeutics

Keywords

  • Adjuvant
  • Chemotherapy
  • Head and neck cancer
  • Induction

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Induction and adjuvant chemotherapy for head and neck cancer : Future perspectives. / Forastiere, Arlene A.

In: Acta Oto-Rhino-Laryngologica Belgica, Vol. 53, No. 3, 1999, p. 277-280.

Research output: Contribution to journalArticle

@article{82efefa028744291bddde89e513d5426,
title = "Induction and adjuvant chemotherapy for head and neck cancer: Future perspectives",
abstract = "Induction and adjuvant chemotherapy for head and neck cancer: future perspectives. Induction and adjuvant chemotherapy have been studied in combined modality trials over the last two decades. Induction chemotherapy as a strategy has failed to improve survival or local-regional control although some studies have reported a decrease in the rate of development of distant metastases. The role of induction chemotherapy is limited to preserving the larynx for patients with larynx or hypopharynx primaries. Trials of adjuvant chemotherapy or chemoradiation in resected patients suggest benefit for those with high risk features (multiple involved nodes, extracapsular extension, positive surgical margin). Definitive randomized studies are in progress in the United States and Europe. New targeted therapies will be investigated in future trials to improve survival.",
keywords = "Adjuvant, Chemotherapy, Head and neck cancer, Induction",
author = "Forastiere, {Arlene A.}",
year = "1999",
language = "English (US)",
volume = "53",
pages = "277--280",
journal = "B-ENT",
issn = "1781-782X",
publisher = "Koninklijke Belgische Vereniging voor ORL Gelaat en Halschirugie",
number = "3",

}

TY - JOUR

T1 - Induction and adjuvant chemotherapy for head and neck cancer

T2 - Future perspectives

AU - Forastiere, Arlene A.

PY - 1999

Y1 - 1999

N2 - Induction and adjuvant chemotherapy for head and neck cancer: future perspectives. Induction and adjuvant chemotherapy have been studied in combined modality trials over the last two decades. Induction chemotherapy as a strategy has failed to improve survival or local-regional control although some studies have reported a decrease in the rate of development of distant metastases. The role of induction chemotherapy is limited to preserving the larynx for patients with larynx or hypopharynx primaries. Trials of adjuvant chemotherapy or chemoradiation in resected patients suggest benefit for those with high risk features (multiple involved nodes, extracapsular extension, positive surgical margin). Definitive randomized studies are in progress in the United States and Europe. New targeted therapies will be investigated in future trials to improve survival.

AB - Induction and adjuvant chemotherapy for head and neck cancer: future perspectives. Induction and adjuvant chemotherapy have been studied in combined modality trials over the last two decades. Induction chemotherapy as a strategy has failed to improve survival or local-regional control although some studies have reported a decrease in the rate of development of distant metastases. The role of induction chemotherapy is limited to preserving the larynx for patients with larynx or hypopharynx primaries. Trials of adjuvant chemotherapy or chemoradiation in resected patients suggest benefit for those with high risk features (multiple involved nodes, extracapsular extension, positive surgical margin). Definitive randomized studies are in progress in the United States and Europe. New targeted therapies will be investigated in future trials to improve survival.

KW - Adjuvant

KW - Chemotherapy

KW - Head and neck cancer

KW - Induction

UR - http://www.scopus.com/inward/record.url?scp=0032736779&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032736779&partnerID=8YFLogxK

M3 - Article

C2 - 10635408

AN - SCOPUS:0032736779

VL - 53

SP - 277

EP - 280

JO - B-ENT

JF - B-ENT

SN - 1781-782X

IS - 3

ER -